Quick answerExpect
warfarin with valve-specific INR monitoring.
Why this is correctACC/AHA guidance excludes mechanical valves from the usual preference for DOACs in atrial fibrillation. The valve type and thromboembolic risk determine the VKA target and monitoring plan.
Easy analogy or mental pictureA mechanical valve requires the anticoagulant lane with established valve evidence, not a convenient shortcut.
Memory hookMechanical valve means VKA, not DOAC substitution.NCLEX decision ruleIdentify the valve before applying the general atrial-fibrillation anticoagulant rule.
Why the other choices are wrongAspirin or clopidogrel alone does not replace anticoagulation, and apixaban is not the expected mechanical-valve therapy.
References
1ACC/AHA 2023 Atrial Fibrillation GuidelineDOAC preference exceptions for mechanical valves and moderate-to-severe mitral stenosis
2ACC/AHA 2020 Valvular Heart Disease GuidelineVKA therapy for mechanical valves, pregnancy counseling, and monitored anticoagulation planning